EYE 0.00% 18.0¢ nova eye medical limited

CMS Proposes Major Increase in Reimbursement for Canaloplasty, page-131

  1. 16,343 Posts.
    lightbulb Created with Sketch. 4384
    Yeah that was mentioned the other day, pretty clear neither had done their research as they didn't even acknowledge the massive growth that has been recorded and probably looked at the $2m cash balance from the most recent audited results (unaware that the cash balance is now $10m with an improving bottom line and plenty of sales to support expenditure).

    The fact that so few investors know about it has created the phenomenal buying opportunities for investors, sooner or later though you'd want this to change and for the stock to move into the spotlight! Best way for that to happens tends to be a rerate itself, so hopefully that happens soon (for some reason rising prices are what attract investors - strange as I would have thought investors would prefer to buy at cheaper prices)

    Looking at the broader market, it seems that we are seeing a rotation from the sexy tech names and towards the forgotten stocks. Smaller companies that have not moved in line with the broader market, and are quickly becoming a target for the bargain hunters. EYE would surely have to be quite appealing to those looking for a bargain, given the very low valuation compared to fundamentals (which are improving at a rapid rate)
 
watchlist Created with Sketch. Add EYE (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.